Evidence map›Paper›PMID 41601935›Full record

ArticleFrontiers in endocrinology2025

Phalangeal bone growth and implications in Turner syndrome.

Min Jae Kang, Roopa Kanakatti Shankar, Youn Hee Jee

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Min Jae KangDepartment of Pediatric Endocrinology, Children's National Hospital, Washington, DC, United States.
Roopa Kanakatti Shankar *Department of Pediatric Endocrinology, Children's National Hospital, Washington, DC, United States.
Youn Hee Jee *Department of Pediatric Endocrinology, Children's National Hospital, Washington, DC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Skeletal abnormalities are common in Turner Syndrome (TS), yet data on objective radiographic markers are limited. We aimed to establish normative reference ranges for phalangeal length ratios and assess their utility in detecting skeletal abnormalities in TS. Methods: We analyzed 4,082 female bone age X-rays (<18 years) from the Radiological Society of North America (RSNA) database after quality screening and outlier exclusion as a reference cohort. Phalangeal length ratios-4th to 3rd metacarpal (4:3 MC), 5th to 3rd metacarpal (5:3 MC), and 5th to 3rd middle phalanx (5:3 MP)-were measured and compared in 81 TS patients seen at a single center. Additional skeletal features such as Results: In reference subjects, 4:3 MC and 5:3 MC ratios remained stable across most age groups, while the 5:3 MP ratio increased with age. TS patients showed a significantly lower 4:3 MC and 5:3 MP ratios (P < 0.001, P = 0.002, respectively) compared to ones from reference subjects. A low 4:3 MC ratio (<-2 SD) was seen in 27.2% of TS patients. The 4:3 MC ratio correlated with height percentile (r = 0.27, P = 0.02). BDA3 was more prevalent in TS compared to reference subjects (13.6% vs. 2.1%, P < 0.001) and associated with low MC ratios. Conclusion: Normative reference ranges for phalangeal length ratios were established and differences in 4:3 and 5:3 MP ratios in patients with TS were identified compared to the reference group. Further studies with larger TS cohorts are needed to confirm the clinical utility of these radiographic biomarkers.

Indexed as

Bone DevelopmentFinger PhalangesTurner SyndromeAdolescentChildChild, PreschoolFemaleHumansInfantRadiographyReference Valuesbone age X-raybrachydactyly type A3metacarpal bonemiddle phalanxSHOX deficiencyTurner syndrome

Identifiers

PMID41601935
PMCPMC12832326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.